Emelie A. Djerf

Statistics

Publications

Citations

H-Index

Active since

2009

Affiliations

Emelie A. Djerf is an author at Linköping University specializing in receptor tyrosine kinase signaling, tyrosine kinase inhibitors, and pharmacology.

Publications per year

2009–2010

Publications

ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: inhibition by gefitinib (ZD1839)

Emelie A. Djerf, Cecilia Trinks, Avni Abdiu et al. · Melanoma Research · 2009 · 44 citations

Medicine, Oncology, Pharmacology +17

The pan-ErbB receptor tyrosine kinase inhibitor canertinib induces ErbB-independent apoptosis in human leukemia (HL-60 and U-937) cells

Cecilia Trinks, Emelie A. Djerf, Anna‐Lotta Hallbeck et al. · Biochemical and Biophysical Research Communications · 2010 · 13 citations

Life Sciences, Oncology, Pharmacology +14

1–2 of 2